Download PDF
Semin Neurol 2015; 35(06): 621-628
DOI: 10.1055/s-0035-1564304
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Current Trends in Treatment of Status Epilepticus and Refractory Status Epilepticus

John P. Betjemann
1   Department of Neurology, University of California, San Francisco, California
› Author Affiliations
Further Information

Publication History

Publication Date:
23 November 2015 (online)

   Permissions and Reprints

Abstract

Status epilepticus is a heterogeneous disorder with varied definitions and presentations. Taken together, all forms of status epilepticus carry significant morbidity and mortality, much of which is dictated by the underlying etiology. Generalized convulsive status epilepticus, which represents a common form, is a true neurologic emergency that requires emergent management. Treatment focuses on stabilizing the patient and aggressive medical management to achieve the timely termination of seizures. For other forms of status epilepticus including nonconvulsive and focal status epilepticus, the goal remains early seizure termination, but the use of intravenous medications should be weighed against the risks associated with these therapies. The diagnostic evaluation of status epilepticus is guided by the patient's history and should be broad, including a screen for toxins, electrolytes, structural abnormalities, and central nervous system infectious and autoimmune/inflammatory etiologies. Considerable research is still needed to improve our understanding of the mechanisms, consequences, and therapy of status epilepticus.

Keywords

seizures - status epilepticus - refractory status epilepticus - epidemiology - prehospital treatment - diagnostic evaluation
 

  • References

  • 1 DeLorenzo RJ, Hauser WA, Towne AR , et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996; 46 (4) 1029-1035
    CrossrefPubMedGoogle Scholar
  • 2 Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology 1998; 50 (3) 735-741
    CrossrefPubMedGoogle Scholar
  • 3 Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA. Time trends in incidence, mortality, and case-fatality after first episode of status epilepticus. Epilepsia 2001; 42 (8) 1031-1035
    CrossrefPubMedGoogle Scholar
  • 4 Knake S, Rosenow F, Vescovi M , et al; Status Epilepticus Study Group Hessen (SESGH). Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 2001; 42 (6) 714-718
    CrossrefPubMedGoogle Scholar
  • 5 Coeytaux A, Jallon P, Galobardes B, Morabia A. Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology 2000; 55 (5) 693-697
    CrossrefPubMedGoogle Scholar
  • 6 Towne AR, Waterhouse EJ, Boggs JG , et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology 2000; 54 (2) 340-345
    CrossrefPubMedGoogle Scholar
  • 7 Claassen J, Mayer SA, Kowalski RG, Emerson RG, Hirsch LJ. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology 2004; 62 (10) 1743-1748
    CrossrefPubMedGoogle Scholar
  • 8 Oddo M, Carrera E, Claassen J, Mayer SA, Hirsch LJ. Continuous electroencephalography in the medical intensive care unit. Crit Care Med 2009; 37 (6) 2051-2056
    CrossrefPubMedGoogle Scholar
  • 9 Kamel H, Betjemann JP, Navi BB , et al. Diagnostic yield of electroencephalography in the medical and surgical intensive care unit. Neurocrit Care 2013; 19 (3) 336-341
    CrossrefPubMedGoogle Scholar
  • 10 Betjemann JP, Nguyen I, Santos-Sanchez C, Douglas VC, Josephson SA. Diagnostic yield of electroencephalography in a general inpatient population. Mayo Clin Proc 2013; 88 (4) 326-331
    CrossrefPubMedGoogle Scholar
  • 11 Kurtz P, Gaspard N, Wahl AS , et al. Continuous electroencephalography in a surgical intensive care unit. Intensive Care Med 2014; 40 (2) 228-234
    CrossrefPubMedGoogle Scholar
  • 12 Dham BS, Hunter K, Rincon F. The epidemiology of status epilepticus in the United States. Neurocrit Care 2014; 20 (3) 476-483
    CrossrefPubMedGoogle Scholar
  • 13 Betjemann JP, Josephson SA, Lowenstein DH, Burke JF. Trends in status epilepticus-related hospitalizations and mortality: redefined in US practice over time. JAMA Neurol 2015; 72 (6) 650-655
    CrossrefPubMedGoogle Scholar
  • 14 DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol 1995; 12 (4) 316-325
    CrossrefPubMedGoogle Scholar
  • 15 Penberthy LT, Towne A, Garnett LK, Perlin JB, DeLorenzo RJ. Estimating the economic burden of status epilepticus to the health care system. Seizure 2005; 14 (1) 46-51
    CrossrefPubMedGoogle Scholar
  • 16 Jenssen S, Gracely EJ, Sperling MR. How long do most seizures last? A systematic comparison of seizures recorded in the epilepsy monitoring unit. Epilepsia 2006; 47 (9) 1499-1503
    CrossrefPubMedGoogle Scholar
  • 17 Kapur J, Macdonald RL. Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors. J Neurosci 1997; 17 (19) 7532-7540
    PubMedGoogle Scholar
  • 18 Jones DM, Esmaeil N, Maren S, Macdonald RL. Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus. Epilepsy Res 2002; 50 (3) 301-312
    CrossrefPubMedGoogle Scholar
  • 19 Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA 1993; 270 (7) 854-859
    CrossrefPubMedGoogle Scholar
  • 20 Shorvon S. What is nonconvulsive status epilepticus, and what are its subtypes?. Epilepsia 2007; 48 (Suppl. 08) 35-38
    PubMedGoogle Scholar
  • 21 Brophy GM, Bell R, Claassen J , et al; Neurocritical Care Society Status Epilepticus Guideline Writing Committee. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012; 17 (1) 3-23
    CrossrefPubMedGoogle Scholar
  • 22 Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons B-F. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002; 59 (2) 205-210
    CrossrefPubMedGoogle Scholar
  • 23 Treiman DM, Meyers PD, Walton NY , et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998; 339 (12) 792-798
    CrossrefPubMedGoogle Scholar
  • 24 Alldredge BK, Gelb AM, Isaacs SM , et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001; 345 (9) 631-637
    CrossrefPubMedGoogle Scholar
  • 25 Silbergleit R, Durkalski V, Lowenstein D , et al; NETT Investigators. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012; 366 (7) 591-600
    CrossrefPubMedGoogle Scholar
  • 26 Browne TR, Kugler AR, Eldon MA. Pharmacology and pharmacokinetics of fosphenytoin. Neurology 1996; 46 (6) (Suppl. 01) S3-S7
    CrossrefPubMedGoogle Scholar
  • 27 Yasiry Z, Shorvon SD. The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies. Seizure 2014; 23 (3) 167-174
    CrossrefPubMedGoogle Scholar
  • 28 Prasad M, Krishnan PR, Sequeira R, Al-Roomi K. Anticonvulsant therapy for status epilepticus. Cochrane Database Syst Rev 2014; 9: CD003723
    PubMedGoogle Scholar
  • 29 Cock HR ; ESETT Group. Established status epilepticus treatment trial (ESETT). Epilepsia 2011; 52 (Suppl. 08) 50-52
    PubMedGoogle Scholar
  • 30 Riviello Jr JJ, Claassen J, LaRoche SM , et al; Neurocritical Care Society Status Epilepticus Guideline Writing Committee. Treatment of status epilepticus: an international survey of experts. Neurocrit Care 2013; 18 (2) 193-200
    CrossrefPubMedGoogle Scholar
  • 31 Meldrum BS, Vigouroux RA, Brierley JB. Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons. Arch Neurol 1973; 29 (2) 82-87
    CrossrefPubMedGoogle Scholar
  • 32 Rabinowicz AL, Correale JD, Bracht KA, Smith TD, DeGiorgio CM. Neuron-specific enolase is increased after nonconvulsive status epilepticus. Epilepsia 1995; 36 (5) 475-479
    CrossrefPubMedGoogle Scholar
  • 33 Meierkord H, Boon P, Engelsen B , et al; European Federation of Neurological Societies. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 2010; 17 (3) 348-355
    CrossrefPubMedGoogle Scholar
  • 34 Legros B, Depondt C, Levy-Nogueira M , et al. Intravenous lacosamide in refractory seizure clusters and status epilepticus: comparison of 200 and 400 mg loading doses. Neurocrit Care 2014; 20 (3) 484-488
    CrossrefPubMedGoogle Scholar
  • 35 Koubeissi MZ, Mayor CL, Estephan B, Rashid S, Azar NJ. Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus. Acta Neurol Scand 2011; 123 (2) 142-146
    CrossrefPubMedGoogle Scholar
  • 36 Rantsch K, Walter U, Wittstock M, Benecke R, Rösche J. Efficacy of intravenous lacosamide in refractory nonconvulsive status epilepticus and simple partial status epilepticus. Seizure 2011; 20 (7) 529-532
    CrossrefPubMedGoogle Scholar
  • 37 Hottinger A, Sutter R, Marsch S, Rüegg S. Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study. CNS Drugs 2012; 26 (9) 761-772
    CrossrefPubMedGoogle Scholar
  • 38 Stojanova V, Rossetti AO. Oral topiramate as an add-on treatment for refractory status epilepticus. Acta Neurol Scand 2012; 125 (2) e7-e11
    CrossrefPubMedGoogle Scholar
  • 39 Towne AR, Garnett LK, Waterhouse EJ, Morton LD, DeLorenzo RJ. The use of topiramate in refractory status epilepticus. Neurology 2003; 60 (2) 332-334
    CrossrefPubMedGoogle Scholar
  • 40 Claassen J, Hirsch LJ, Mayer SA. Treatment of status epilepticus: a survey of neurologists. J Neurol Sci 2003; 211 (1-2) 37-41
    CrossrefPubMedGoogle Scholar
  • 41 Holtkamp M, Masuhr F, Harms L, Einhäupl KM, Meierkord H, Buchheim K. The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists. J Neurol Neurosurg Psychiatry 2003; 74 (8) 1095-1099
    CrossrefPubMedGoogle Scholar
  • 42 DeLorenzo RJ, Waterhouse EJ, Towne AR , et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 1998; 39 (8) 833-840
    CrossrefPubMedGoogle Scholar
  • 43 Holtkamp M, Othman J, Buchheim K, Meierkord H. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 2005; 76 (4) 534-539
    CrossrefPubMedGoogle Scholar
  • 44 Novy J, Logroscino G, Rossetti AO. Refractory status epilepticus: a prospective observational study. Epilepsia 2010; 51 (2) 251-256
    CrossrefPubMedGoogle Scholar
  • 45 Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol 2005; 62 (11) 1698-1702
    CrossrefPubMedGoogle Scholar
  • 46 Hocker SE, Britton JW, Mandrekar JN, Wijdicks EF, Rabinstein AA. Predictors of outcome in refractory status epilepticus. JAMA Neurol 2013; 70 (1) 72-77
    CrossrefPubMedGoogle Scholar
  • 47 Rossetti AO, Lowenstein DH. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol 2011; 10 (10) 922-930
    CrossrefPubMedGoogle Scholar
  • 48 Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain 2011; 134 (Pt 10): 2802-2818
    CrossrefPubMedGoogle Scholar
  • 49 Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002; 43 (2) 146-153
    PubMedGoogle Scholar
  • 50 Prüss H, Holtkamp M. Ketamine successfully terminates malignant status epilepticus. Epilepsy Res 2008; 82 (2-3) 219-222
    CrossrefPubMedGoogle Scholar
  • 51 Esaian D, Joset D, Lazarovits C, Dugan PC, Fridman D. Ketamine continuous infusion for refractory status epilepticus in a patient with anticonvulsant hypersensitivity syndrome. Ann Pharmacother 2013; 47 (11) 1569-1576
    CrossrefPubMedGoogle Scholar
  • 52 Hsieh CY, Sung PS, Tsai JJ, Huang CW. Terminating prolonged refractory status epilepticus using ketamine. Clin Neuropharmacol 2010; 33 (3) 165-167
    CrossrefPubMedGoogle Scholar
  • 53 Gaspard N, Foreman B, Judd LM , et al. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia 2013; 54 (8) 1498-1503
    CrossrefPubMedGoogle Scholar
  • 54 Mirsattari SM, Sharpe MD, Young GB. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol 2004; 61 (8) 1254-1259
    CrossrefPubMedGoogle Scholar
  • 55 Walker IA, Slovis CM. Lidocaine in the treatment of status epilepticus. Acad Emerg Med 1997; 4 (9) 918-922
    CrossrefPubMedGoogle Scholar
  • 56 Hamano S, Sugiyama N, Yamashita S , et al. Intravenous lidocaine for status epilepticus during childhood. Dev Med Child Neurol 2006; 48 (3) 220-222
    CrossrefPubMedGoogle Scholar
  • 57 Hattori H, Yamano T, Hayashi K , et al. Effectiveness of lidocaine infusion for status epilepticus in childhood: a retrospective multi-institutional study in Japan. Brain Dev 2008; 30 (8) 504-512
    CrossrefPubMedGoogle Scholar
  • 58 Visser NA, Braun KP, Leijten FS, van Nieuwenhuizen O, Wokke JH, van den Bergh WM. Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations. J Neurol 2011; 258 (2) 218-222
    CrossrefPubMedGoogle Scholar
  • 59 Ferlisi M, Shorvon S. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain 2012; 135 (Pt 8): 2314-2328
    CrossrefPubMedGoogle Scholar
  • 60 Bodenant M, Moreau C, Sejourné C , et al. [Interest of the ketogenic diet in a refractory status epilepticus in adults]. Rev Neurol (Paris) 2008; 164 (2) 194-199
    CrossrefPubMedGoogle Scholar
  • 61 Caraballo RH, Flesler S, Armeno M , et al. Ketogenic diet in pediatric patients with refractory focal status epilepticus. Epilepsy Res 2014; 108 (10) 1912-1916
    CrossrefPubMedGoogle Scholar
  • 62 Cobo NH, Sankar R, Murata KK, Sewak SL, Kezele MA, Matsumoto JH. The ketogenic diet as broad-spectrum treatment for super-refractory pediatric status epilepticus: challenges in implementation in the pediatric and neonatal intensive care units. J Child Neurol 2015; 30 (2) 259-266
    CrossrefPubMedGoogle Scholar
  • 63 Kamel H, Cornes SB, Hegde M, Hall SE, Josephson SA. Electroconvulsive therapy for refractory status epilepticus: a case series. Neurocrit Care 2010; 12 (2) 204-210
    CrossrefPubMedGoogle Scholar
  • 64 Shin HW, O'Donovan CA, Boggs JG , et al. Successful ECT treatment for medically refractory nonconvulsive status epilepticus in pediatric patient. Seizure 2011; 20 (5) 433-436
    CrossrefPubMedGoogle Scholar
  • 65 Tan RY, Neligan A, Shorvon SD. The uncommon causes of status epilepticus: a systematic review. Epilepsy Res 2010; 91 (2-3) 111-122
    CrossrefPubMedGoogle Scholar
  • 66 Lowenstein DH, Walker M, Waterhouse E. Status epilepticus in the setting of acute encephalitis. Epilepsy Curr 2014; 14 (1, Suppl): 43-49
    CrossrefPubMedGoogle Scholar
  • 67 Knudsen FU. Rectal administration of diazepam in solution in the acute treatment of convulsions in infants and children. Arch Dis Child 1979; 54 (11) 855-857
    CrossrefPubMedGoogle Scholar
  • 68 Scott RC, Besag FM, Neville BG. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet 1999; 353 (9153) 623-626
    CrossrefPubMedGoogle Scholar
  • 69 Lahat E, Goldman M, Barr J, Bistritzer T, Berkovitch M. Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study. BMJ 2000; 321 (7253) 83-86
    CrossrefPubMedGoogle Scholar
  • 70 Cereghino JJ, Cloyd JC, Kuzniecky RI ; North American Diastat Study Group. Rectal diazepam gel for treatment of acute repetitive seizures in adults. Arch Neurol 2002; 59 (12) 1915-1920
    CrossrefPubMedGoogle Scholar
  • 71 McIntyre J, Robertson S, Norris E , et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet 2005; 366 (9481) 205-210
    CrossrefPubMedGoogle Scholar